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Summary
Background:  Hospital-acquired  infections  (HAIs)  are  critical  and  mostly  preventable
complications  that  occur  in  hospitalized  patients  and  lead  to  major  health  and  eco-
nomic  burdens.  Most  of  the  information  on  HAI  risk  factors  and  the  recommended
preventive  measures  is  based  on  data  acquired  from  only  a  few  countries.  The  aim  of
this  point  prevalence  HAI  study  conducted  in  Shiraz,  Iran,  was  to  study  the  local  epi-
demiology  of  HAIs  and  the  major  risk  factors  for  acquiring  HAIs  in  a  Middle-Eastern
region.
Methods:  The  study  employed  four  identical  point  prevalence  surveys  in  eight  uni-
versity  hospitals,  each  consisting  of  60—700  beds.  The  study  was  conducted  during
all  four  season  of  2008—2009.  All  of  the  patients  admitted  for  ≥48  h  were  studied,
although  the  patients  admitted  to  emergency  wards  were  excluded.  A  standardized
data  collection  form  that  included  name,  age,  gender,  presence  or  absence  of  HAI,
administration  of  any  antibiotics,  insertion  of  a  central  line,  use  of  an  endotracheal
tube,  mechanical  ventilation,  and  use  of  an  urinary  catheter  was  completed  for
each  patient.  The  HAI  deﬁnitions  used  in  this  study  were  based  on  the  US  National
Nosocomial  Infection  Surveillance  (NNIS)  guidelines.
Results:  Data  from  3450  patients  were  prospectively  collected  and  analyzed.  The
overall  HAI  prevalence  was  9.4%.  The  most  common  HAIs  were  blood  stream  infec-
tions  (2.5%),  surgical  site  infections  (2.4%),  urinary  tract  infections  (1.4%),  and
pneumonia  (1.3%).  A  logistic  regression  analysis  showed  that  the  odds  ratio  OR  for
males  rather  than  females  acquiring  infections  was  1.56  (95%  conﬁdence  interval  [CI]
1.21—2.02).  Other  HAI  risk  factors  included  using  a  central  intravascular  catheter,
adjusted  OR  of  3.86  (95%  CI  2.38—6.26),  and  using  an  urinary  catheter,  adjusted  OR
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of  3.06  (95%  CI  2.19—4.28).  
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Introduction
Hospital  acquired  infections  (HAIs)  are  one  of  the
most critical  complications  in  hospitalized  patients
and are  responsible  for  major  health  and  economic
burdens  [1].  HAIs  double  the  medical  care  costs  of
infected patients  [2],  and  it  is  estimated  that  80%  of
all hospital  deaths  are  directly  or  indirectly  related
to HAIs  [3].  Recent  studies  conducted  at  multiple
locations worldwide  have  reported  HAI  prevalences
ranging from  4%  to  47%  [4—15].
Epidemiological  data  support  the  position  that
HAI risk  is  associated  with  multiple  variables  (e.g.,
patient’s  age,  pre-existing  underlying  disease,
length of  hospital  stay,  an  immune-compromised
state,  and  the  presence  of  invasive  medical
devices, such  as  urinary  catheters,  central  lines,
and ventilation)  and  that  HAIs  can  be  prevented
through adequate  preventative  measures  [3].  A
point prevalence  study  of  HAIs  in  Saudi  Arabia
demonstrated a  12.7-fold  increased  risk  associated
with  a  hospital  stay  exceeding  eight  days  [10].  A
prospective  study  conducted  in  Slovenia  identiﬁed
the presence  of  central  and  peripheral  vascular
catheters, urinary  catheters  and  admission  to  inten-
sive care  units  as  signiﬁcant  risk  factors  [16].
Surveillance  has  been  accepted  as  a primary  ele-
ment of  preventing  and  controlling  HAIs.  Although
continuous  prospective  surveillance  for  HAIs  is  the
gold standard,  this  approach  requires  comprehen-
sive resources.  Therefore,  point  prevalence  surveys
are preferred  for  determining  the  magnitude  of
HAIs in  countries  with  limited  resources.  Such  stud-
ies are  inexpensive  and  do  not  require  extensive
resources [3].
Most  of  the  information  on  HAI  risk  factors  and
the recommended  preventive  measures  is  based
on data  from  a  small  number  of  countries,  mainly
from  North  America  and  Europe.  Therefore,  the
aim of  this  point  prevalence  HAI  study  conducted
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Being  admitted  to  an  ICU  was  not  an  independent  HAI
R  of  acquiring  infection  was  3.24  (95%  CI  2.34—4.47)  in
ays  longer  than  eight  days.  A  high  discrepancy  between
observed.  Antibiotics  were  administered  to  71%  of  the
e  patients  also  had  at  least  one  documented  infection.
lence  study  showed  that  HAIs  are  frequent  in  Shiraz  uni-
he  proportion  of  patients  receiving  antibiotics  is  high.
rimary  prevention  efforts  are  necessary  to  address  HAIs
ling  devices  and  to  prevent  surgical  site  infections.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
n Shiraz,  Iran,  was  to  study  the  local  epidemiol-
gy of  HAIs  and  the  major  related  risk  factors  for
cquiring  HAIs  in  a  Middle-Eastern  region.  This  study
sed the  criteria  of  the  Centers  for  Disease  Con-
rol and  Prevention’s  (CDC’s)  National  Healthcare
afety Network  (NHSN)  [17]  to  deﬁne  HAIs  in  a  clus-
er of  university-afﬁliated  hospitals  associated  with
he Shiraz  University  of  Medical  Sciences,  Iran.
aterials and methods
he  study  was  designed  as  a prospective  point
revalence survey  measured  at  four  points,  using
n identical  design  and  repeating  the  study  design
t identical  settings.  The  data  collection  period
or the  survey  was  randomly  determined  by  using
 random  number  table  to  select  3-month  inter-
als corresponding  to  the  seasons,  including  the
pring  of  2008,  summer  of  2008,  autumn  of  2008,
nd winter  of  2008/2009.  The  study  was  con-
ucted during  May—June  2008/August—September
008/December  2008/February  2009  at  eight  uni-
ersity afﬁliated  hospitals  in  Shiraz,  Iran.  The
articipating  hospitals  had  60—700  beds.  These
ight  hospitals  serve  as  referral  hospitals  for  the
outhern  region  of  Iran.  All  of  the  patients  admitted
or ≥48  h were  studied,  although  patients  admitted
o the  emergency  rooms  were  excluded.  All  of  the
atients  were  visited  at  least  once  a  day.  A  history
nd physical  examination  were  conducted  for  each
atient, and  all  of  the  laboratory  results  and  med-
cal charts  were  reviewed  carefully.  If  necessary,
nterviews with  the  treating  physicians  were  con-
ucted. If the  laboratory  data  or  medical  records
ere not  available,  the  ward  and  patients  were
isited  again  and  the  data  collection  form  was  com-
leted. The  data  collection  form  included  name,
ge, gender,  chart  number,  name  of  the  hospi-
al, name  of  the  ward,  date  of  admission,  medical
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iagnosis  of  the  patient,  administration  of  antibi-
tics, presence  of  a  fever,  use  of  a  central  or
eripheral  intravascular  line,  use  of  an  endotra-
heal tube,  mechanical  ventilation,  and  the  use  of
 Foley  or  any  other  urinary  catheter.
The patients  that  had  a  blood-stream  infec-
ion, ventilator-associated  pneumonia,  a surgical
ite infection,  an  urinary  tract  infection  or  any
ther  hospital  acquired  infection  were  investigated
n further  detail.  An  infection  was  deﬁned  to  be
ospital-acquired  using  the  NHSN  deﬁnitions  [17].
ll HAIs  were  considered  when  calculating  preva-
ence and  ranking,  even  if  one  patient  had  two
r more  infections.  When  calculating  risk  factors,
owever,  only  the  ﬁrst  HAI  occurring  in  a patient
as considered.  When  calculating  odds  ratios  (ORs)
o assess  the  associated  risk  factors,  the  patients
ith HAIs  were  compared  to  matched  (age,  gen-
er, admission  date,  ward,  and  underlying  disease)
atients  without  HAIs  who  were  identiﬁed  on  the
ame day  and  at  the  same  facility.
tatistical analysis
he  data  were  analyzed  by  SPSS  for  windows  ver-
ion 11.5.  Percentages  were  compared  using  the
hi-square  test  and  means  were  compared  using
tudent’s  T-test.  The  variables  with  P-values  ≤0.05
n the  univariate  tests  were  further  analyzed  in
 multivariate  analysis  using  a  multiple  logistic
egression  model.  Maximum  likelihood  estimates  of
dds ratios  with  their  95%  conﬁdence  intervals  were
alculated.  A  P-value  of  <0.05  was  regarded  as  a
tatistically  signiﬁcant  difference.
esults
eneral patient characteristicsuring  the  4  point  prevalence  survey  periods,  a
otal of  323  HAIs  were  identiﬁed  among  3450
atients (9.4%).  A  total  of  1701  male  and  1742
f
e
h
r
Table  1  Prevalence  of  HAIs  during  the  four  study  seasons.
Date  Total  number
of  patients
No  infection
No (%)
UTI
No  (%)
Spring  956  869  (90.9)  10  (1.0)  
Summer  909  813  (89.4)  14  (1.5)  
Autumn  853  768  (90.0)  17  (2.0)  
Winter  732  677  (92.5)  7  (1.0)  
Total  3450  3127  (90.6)  48  (1.4)  
UTI, urinary tract infection; BSI, bloodstream infection; SSI, surgi
infection; Chi-square (2) = 4.93, 3 df, (P = 0.177).171
50.6%)  female  patients  were  investigated  for  the
resence of  HAIs.  The  ages  of  the  patients  ranged
rom  less  than  1 month  to  90  years  (median  = 32
ears). The  mean  age  was  35.3  ±  23.7  years  among
he males  and  33.2  ±  20.4  years  among  the  females.
o statistically  signiﬁcant  seasonal  differences  in
revalence were  observed  between  the  four  inves-
igated  seasons  (chi  = 4.93,  3  df,  P =  0.177;  Table  1).
The most  frequent  HAIs  were  blood  stream  infec-
ions  (BSI,  2.5%),  surgical-site  infections  (SSI,  2.4%),
rinary tract  infections  (UTI;  1.4%),  and  pneumo-
ia (PNEU;  1.3%).  A  high  prevalence  of  HAIs  was
bserved  in  medical  (non-surgical)  ICUs  (28.9%,
2/76 patients  diagnosed  with  HAIs)  and  burn  units
37.5%, 38/63  patients  diagnosed  with  HAI).  The
bsolute  numbers  and  prevalence  rates  of  all  HAIs
mong the  patients,  stratiﬁed  by  medical  specialty
nd level  of  care  are  shown  in  Table  2.
isk factors
he  distribution  of  the  main  HAI  subgroup  (BSI,
SI, UTI  and  PNEU)  was  signiﬁcantly  different
etween the  male  and  female  patients  (Table  3).
he HAI  prevalence  was  higher  in  the  male  than  in
he female  patients  (males  =  11.8%,  females  = 7%).
ospital-acquired  UTIs  were  found  in  5.4%  (31/544)
f the  patients  with  a  urinary  catheter.  Hospital-
cquired pneumonia  was  reported  in  9.8%  (24/222)
f the  intubated  patients,  and  14.2%  (36/218)  of
atients with  a central  vascular  line  had  hospital-
cquired BSIs.
The  multiple  logistic  regression  model  for  HAIs
howed  that  the  presence  of  an  urinary  catheter,
n intubation  tube,  an  intra-vascular  line  and  a
ospital stay  of  more  than  8  days  were  signif-
cantly associated  with  HAI  incidence  (P  ≤  0.05).
fter correcting  for  confounders  in  the  multiple
ogistic analysis  model,  the  most  important  risk
actors for  hospital-acquired  UTIs  were  the  pres-
nce of  an  urinary  catheter  and  an  extended
ospital stay  (P  ≤  0.001).  For  pneumonia,  the  most
elevant factors  were  intubation  and  ventilators
SSI
No (%)
PNEU
No (%)
BSI
No (%)
Other  HAIs
No  (%)
25  (2.6)  12  (1.3)  21  (2.2)  19  (2.0)
22  (2.4)  13  (1.4)  28  (3.1)  19  (2.1)
22  (2.6)  14  (1.6)  19  (2.2)  13  (1.5)
14  (1.9)  7  (1.0)  18  (2.5)  9  (1.2)
83  (2.4)  46  (1.3)  86  (2.5)  60  (1.7)
cal site infection; PNEU, pneumonia; HAI, hospital acquired
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Table  2  Prevalence  of  HAIs  stratiﬁed  by  medical  specialty.
Clinical  unit  Total  infections
No  (%)
UTI
No (%)
SSI
No  (%)
PNEU
No  (%)
BSI
No  (%)
Other  HAIs
No  (%)
Surgical 479  (93.9)  9  (1.8)  13  (2.5)  3  (0.6)  5  (1)  1  (0.2)
Internal  medicine  458  (92.7)  8  (1.6)  4  (0.8)  4  (0.3)  19  (3.8)  1  (0.2)
Surgical  ICU 236  (82.8)  6  (2.1)  11  (3.9)  12  (4.2)  15  (5.3)  5  (1.8)
Medical  ICU 54 (71.1)  4  (5.3)  2  (2.6)  10  (13.2)  6  (7.9)  0  (0.0)
Pediatric 249 (96.1)  1 (0.4)  3 (1.2)  0  (0) 5  (1.9)  1  (0.4)
Pediatric  ICU 30 (93.8)  1 (3.1)  0 0 1 (3.1)  0
CCU 98 (89.9)  6 (5.5)  0 2 (1.8)  2 (1.8)  1 (0.9)
N  ICU  172  (81.5)  1  (0.5)  1  (0.5)  8  (3.8)  16  (7.6)  13  (6.2)
Pediatric  surgery  61  (88.4)  2  (2.9)  4  (5.8)  0  1  (1.4)  1  (1.4)
Transplant  85  (97.7)  0  0  0  2  (2.3)  0
Dermatology  35  (97.7)  0  0  0  0  1  (2.8)
OB  &  GYN  401  (96.4)  0  6  (1.4)  0  7  (1.7)  2  (0.5)
Orthopedic  345  (89.4)  4  (1)  31  (8)  1  (3)  2  (0.5)  3  (0.8)
Neurosurgical  113  (90.4)  1  (0.8)  6  (4.8)  3  (24)  1  (0.8)  1  (0.8)
Rehabilitation  28  (93.3)  0  0  2  (6.7)  0  0
Ophthalmology  51  (96.2)  0  1  (1.9)  0  0  1  (1.9)
ENT  61  (98.4)  0  0  0  0  1  (1.6)
Psychiatric 108  (100) 0  0  0  0  0
Burns 63 (62.4)  5  (5)  1  (1)  0  4  (4)  28  (27.7)
Total 3127 (90.6)  48 (1.4)  83  (2.4)  46  (1.3)  86  (2.5)  60  (1.7)
UTI, urinary tract infection; BSI, bloodstream infection; SSI, surgical site infection; PNEU, pneumonia; HAI, healthcare associated
infection; ICU, intensive care unit; OB, obstetrics; GYN, gynecology; ENT, Ear-, Nose-, Throat. Chi-square (2) 0 342.39; 72 df,
(P ≤ 0.001).
Table  3  Prevalence  of  HAIs  stratiﬁed  by  gender.
Gender No  infection
No (%)
All infections
No (%)
UT I
No (%)
SSI
No  (%)
PNEU
No  (%)
BSI
No  (%)
Other  HAIs
No  (%)
Female1620 (93)  122  (7)  16  (0.9)  33  (1.9)  16  (0.9)  33  (1.9)  24  (1.4)
Male  1500  (88.2)  201  (11.8)  32  (1.9)  50  (2.9)  30  (1.8)  53  (3.1)  36  (2.1)
Total 3120  (90.6)  323  (9.4)  48  (1.4)  83  (2.4)  46  (1.3)  86  (2.5)  60  (1.7)
P-value ≤0.0001  0.016  0.046  0  0.031  0.022  0.098
surgi
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DUTI, urinary tract infection; BSI, bloodstream infection; SSI, 
infection. 2 = 24.25, 5 df, (P ≤ 0.001).
and  an  extended  hospital  stay.  The  presence  of
an intra-vascular  line  and  intubation  were  associ-
ated with  hospital  acquired  BSIs.  The  associations
between different  HAI  risk  factors  and  HAI  inci-
dence  observed  in  the  multiple  logistic  regression
analyses are  shown  in  Table  4.
Antibiotic use
Administration  of  antibiotics  was  noted  in  70.9%
(2446/3450)  of  the  surveyed  patients.  However,
only 9.4%  (323/3450)  of  the  surveyed  patients  also
had at  least  one  documented  infection.  The  treat-
ing physicians  were  asked  about  their  reasons  for
administering  antibiotics  in  2123  of  the  remaining
patients and  they  either  stated  that  the  patients
were given  antibiotics  for  prophylactic  reasons  or
T
m
l
Ical site infection; PNEU, pneumonia; HAI, hospital acquired
o  clinical  justiﬁcation  for  administering  antibiotics
ould  be  given.  Furthermore,  in  those  patients  that
ere given  antibiotics  for  prophylactic  reasons,  the
lasses of  antibiotic  and  the  durations  of  therapy
ere appropriate  for  treatment  rather  than  infec-
ion prophylaxis  regimens.
Antibiotic  use  was  high  among  most  of  the  med-
cal services  and  most  frequent  in  the  ICUs  (88.7%
f the  patients  [522/588]).
iscussiono  our  knowledge,  the  results  presented  in  this
anuscript  represent  the  largest  prospectively  col-
ected point  prevalence  study  of  HAIs  conducted  in
ran to  date.  Data  from  a total  of  3450  patients  were
Risk  factors  of  hospital  acquired  infections  173
Table  4  Multiple  logistic  regression  results  for  HAI  incidence  and  various  risk  factors.
Risk  factor  No  (%)  Odds  ratio  P-value  (95%  CI)
All  infections  323  0.001
Male  201  (11.8)  1.562  (1.21—2.017)
Female  122  (7)  1
Urinary  catheter
All  infections ≤0.001
Yes 133 (23.1)  3.059  (2.185—4.282)
No 190 (6.6)  1
UTI  ≤0.001
Yes  31  (5.4)  12.17  (6.009—24.6)
No  17  (0.06)  1
Intubation
All  infections 0.016
Yes  74  (30.1)  1.742  (1.107—2.741)
No  249  (7.8)  1
PNEU  0.017
Yes  24  (9.8)  3.014  (1.215—7.477)
No  22  (0.07)  1
BSI 0.006
Yes 29 (11.8)  2.755  (1.335—5.683)
No 57 (1.8)  1
Length  of  hospital  stay
All  infections ≤0.001
<8  days 125 (5.3)  1
8—13  days  75 (16.1)  3.4
>13  days 123 (20.8)  4.40  (3.350—5.950)
UTI ≤0.001
<8  days 20 (0.8)  1
8—13  days  11 (2.4)  3.004  (1.397—6.459)
>13  days 17 (2.9)  3.628  (1.815—7.252)
BSI  ≤0.001
<8  days  26  (1.1)  1
8—13  days  22  (4.7)  3.597  (1.977—6.545)
>13  days  38  (6.4)  4.548  (2.663—7.766)
Intra  vascular  line
All  infections
No 46  (3.9)  1
Peripheral  203  (10.1)  1.989  ≤0.001  (1.403—2.820)
Central  73  (28.7)  3.861  ≤0.001  (2.380—6.264)
BSI
No  6  (0.5)  1
Peripheral  44  (2.2)  3.075  0.012  (1.286—7.353)
Central  36  (14.2)  17.119  ≤0.001  (6.423—45.624)
Age  group
All  infections  ≤0.001
≤18  years  42  (16.5)  1
19—49  years  179  (7.8)  0.356  (0.217—0.584)
≥50  years  102  (11.6)  0.393  (0.231—0.669)
UTI, urinary tract infection; BSI, bloodstream infection; SSI, surgical site infection; PNEU, pneumonia. The maximum likelihood
als (
i
i
M
c
t
destimates for the odds ratios and their 95% conﬁdence interv
(P-values) were computed using logistic regression.
ncluded  in  this  study.  Only  a  few  systematic  stud-
es on  HAI  frequency  have  been  conducted  in  Iran.
ost of  those  studies  used  different  methodologies,
onducted incidence  vs.  prevalence  studies,  inves-
igated different  patient  populations,  and  used
w
d
a95% CI) and likelihood ratio tests for signiﬁcant associations
ifferent  case  deﬁnitions  for  the  HAIs  in  question,
hich makes  comparing  the  results  difﬁcult.
A study  similar  to  the  current  study  was  con-
ucted in  Iran  in  2004  (the  ﬁrst  time  that  such
 study  was  conducted  in  Iran).  The  prevalence
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reported  in  that  study  [15]  was  moderately  higher
than the  9.4%  prevalence  reported  here.  However,
the  2004  study  considered  only  three  HAIs  (UTI,  SSI,
and BSI)  and  did  not  study  the  associated  risk  fac-
tors [15].
The 9.4%  HAI  prevalence  reported  in  this  study  is
high compared  to  the  published  results  from  other
recently  conducted  national  HAI  surveys  from  other
countries,  which  have  ranged  between  4%  and  8%
[5—8]. Furthermore,  our  study  showed  a  high  num-
ber of  young  patients  diagnosed  with  HAIs.  These
differences  can  be  explained  by  the  mean  age  of
the Iranian  population  being  low  (28  years)  [18].
Point prevalence  studies  are  performed  by  inves-
tigating  a  deﬁned  population  over  one  day  or  other
short time  period.  Therefore,  the  results  obtained
from  studies  using  identical  hospitals  and  similar
designs  can  differ  by  the  season  of  the  year  and
the number  of  patients  admitted  to  each  ward
(the ‘‘patient  load’’)  [10].  To  avoid  this  prob-
lem, we  conducted  our  survey  using  an  identical
study design  at  each  of  the  four  different  sea-
sons so  that  we  could  evaluate  the  effects  of  the
four different  weather  conditions  and  of  different
patient  loads.  Although  we  carefully  controlled  for
possible seasonal  inﬂuences  in  the  HAI  frequency,
our ﬁnal  analysis  showed  no  signiﬁcant  differences
between the  four  seasons.  Seasonality  certainly
plays a  role  in  the  frequency  of  certain  infec-
tion, such  as  inﬂuenza  [19],  malaria  [20,21],  or
rotavirus gastroenteritis  [22].  Although  few  stud-
ies have  investigated  the  association  of  seasonal
climate effects,  some  have  been  able  to  show  an
inﬂuence  on  the  frequency  of  SSIs  [23]  or  device
related infections,  such  as  central  venous  catheter
related  BSIs  [24].
The  most  common  HAI  observed  in  our  survey
was BSI.  This  ﬁnding  is  consistent  with  the  results
from a  study  conducted  in  Saudi  Arabia  [13],  but
is inconsistent  with  the  results  of  the  prevalence
study conducted  in  Shiraz  in  2004  [15].  The  high
BSI frequency  found  in  the  present  study  may  be
explained  by  the  presence  of  multiple  risk  fac-
tors related  to  BSI,  such  as  the  high  prevalence  of
intravascular  lines  in  the  investigated  wards  (surgi-
cal, medical  and  pediatrics)  and  the  length  of  stay
of the  patients  at  the  university  hospitals  in  Shiraz.
Admission  to  an  ICU  was  not  an  independent
HAI risk  factor  in  the  multiple  logistic  regression
analysis. This  ﬁnding  may  have  been  due  to  not
measuring  independent  risk  factors  in  the  patients
who were  not  in  ICUs  or  to  the  relatively  high  expo-
sures of  non-ICU  patients  to  invasive  procedures,
such as  central  lines,  Foley  catheters  and  endotra-
cheal  intubation.  Situations  where  non-ICU  patients
are subjected  to  more  invasive  medical  procedures
w
v
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han  ICU  patients  are  unusual  and  are  in  contrast  to
ost of  the  published  literature  [10,15,16,25].
Similar  to  the  results  reported  by  other  stud-
es [10,16],  however,  we  also  found  signiﬁcant
ifferences by  sex.  The  odds  of  experiencing  an
AI were  higher  in  male  patients  than  in  female
atients, particularly  for  UTI  and  pneumonia,  but
o gender  difference  was  observed  in  the  results  of
he prevalence  study  conducted  in  Shiraz  in  2004.
imple regression  analyses  were  ﬁrst  employed  to
dentify the  possible  risk  factors  for  acquiring  infec-
ion, and  these  factors  were  then  analyzed  in  a
tepwise  logistic  regression  analysis  to  eliminate
onfounding. This  approach  allowed  us  to  show
n association  between  a  prolonged  hospital  stay
longer than  eight  days)  and  HAI  incidence  (mostly
SI or  UTI).  This  association  has  been  demonstrated
n other  published  studies  [8,13].  Moreover,  the
resence  of  intubation  was  a major  risk  factor  for
cquiring  BSIs,  along  with  pneumonia  itself.  Sim-
lar to  other  studies  [13,25],  the  results  of  our
tudy showed  that  invasive  medical  devices  (urinary
atheters,  endotracheal  tubes  and  intra-vascular
ines) increase  the  risk  of  HAIs  and  require  strict
reventive measures  to  prevent  and  control  infec-
ion.
Our study  had  some  additional  ﬁndings  that  were
nteresting  in  light  of  previously  published  work.
 high  HAI  incidence  was  observed  in  medical
CUs; however,  the  observed  HAI  incidence  among
CU patients  (18%)  was  lower  than  the  reported
ange of  HAI  rates  in  ICUs  from  other  countries
5,10,16]. One  explanation  for  this  observation  may
e that  most  patients  requiring  intensive  care  are
ot admitted  to  ICUs  but  are  cared  for  at  medical
ards because  of  limited  ICU  beds.
The most  prominent  result  of  this  study  was  the
igh rate  of  antibiotic  use  (71%),  which  was  among
ighest  reported  among  studies  with  a  similar
esign [5,26].  Most  of  the  antibiotics  were  intended
o treat  or  prevent  HAIs.  If  a  single  NHSN  HAI  cri-
erion, antibiotic  use,  were  sufﬁcient  to  identify
n HAI,  the  HAI  prevalence  in  our  study  would
ave been  71%.  However,  the  high  rate  of  antibiotic
se we  found  was  lower  than  the  results  reported
rom other  Iranian  studies  conducted  in  the  surgi-
al wards  of  Shiraz  hospitals  in  2004  [27,28].  The
ighest rate  antibiotic  use  was  observed  for  the
eonatal  ICUs  (94%  of  the  patients  [198/211]),  and
he lowest  rates  were  observed  for  the  cardiac  care
nits [50%  of  the  patients  (47/94)]  and  the  pediatric
ards [63.5%  of  the  patients  (165/259)].
Our  study  has  some  limitations.  First,  the  study
as performed  in  multiple  hospitals,  but  only  uni-
ersity hospitals  were  included.  Our  results  do  not
llow conclusions  about  the  possible  HAI  incidences
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t  private  facilities.  Second,  although  the  data
ere prospectively  collected,  the  study  was  not
onducted  longitudinally,  and  the  cross  sectional
tudy design  did  not  allow  establishing  causality
etween different  factors;  in  particular,  it  was  not
ossible to  interpret  which  factor  came  ﬁrst.  Fur-
hermore,  one-day  point  prevalence  studies  tend
o overestimate  persistent  infections  and  underes-
imate  infections  with  shorter  durations.  Third,  our
tudy did  not  investigate  the  different  risk  factors
eading  to  HAIs,  such  as  underling  disease,  previous
ospitalizations,  surgical  procedures,  frequency  of
ays before  surgery,  admission  to  the  emergency
ard and  the  need  to  perform  invasive  procedures
nder emergency  conditions.
In conclusion,  several  results  of  this  prevalence
tudy are  noteworthy.  The  prevalence  of  HAIs  is
igh. Because  HAIs  represent  an  important  public
ealth  problem  in  Iran,  a  crude  baseline  prevalence
ate has  been  established,  implying  the  urgent  need
or a  nationwide  HAI  surveillance  system.  The  high
ate of  BSIs  and  SSIs  requires  further  investigation
o identify  their  associated  risk  factors  and  the  pos-
ible measures  for  preventing  them.  Finally,  the
revalent  misuse  of  antibiotics  in  the  investigated
acilities will  lead  to  the  development  and  spread
f multi-resistant  pathogens  if  the  use  of  antibiotics
s not  controlled  soon.
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